A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

Clinical trial NCT05972720 · TERMINATED

Trial details

NCT number: NCT05972720
Sponsor: CARGO Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Start date: 2023-08-01
Primary completion: 2025-04-04
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.